Analyst emphasizes 2021 guidance in Genmab fiscal report
On Tuesday, Danish biotech firm Genmab presents its annual report, and according to bank analyst Søren Løntoft Hansen, special attention will be given to the current year's guidance.
BY RITZAU FINANS, TRANSLATED BY NIELSINE NIELSEN
Genmab's 2021 guidance is an unknown variable for when biotech companies start presenting fiscal reports on Tuesday after the stock market closes.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg&w=384&q=75)
